Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Arnold SV"" wg kryterium: Autor


Tytuł :
Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry.
Autorzy :
Arnold SV
Chan PS
Jones PG
Decker C
Buchanan DM
Krumholz HM
Ho PM
Spertus JA
Cardiovascular Outcomes Research Consortium
Arnold, Suzanne V
Chan, Paul S
Jones, Philip G
Decker, Carole
Buchanan, Donna M
Krumholz, Harlan M
Ho, P Michael
Spertus, John A
Pokaż więcej
Źródło :
Circulation: Cardiovascular Quality & Outcomes; Jul2011, Vol. 4 Issue 4, p467-476, 10p
Czasopismo naukowe
Tytuł :
Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38.
Autorzy :
Mahoney EM
Wang K
Arnold SV
Proskorovsky I
Wiviott S
Antman E
Braunwald E
Cohen DJ
Pokaż więcej
Źródło :
Circulation; 1/5/2010, Vol. 121 Issue 1, p71-79, 9p
Czasopismo naukowe
Tytuł :
The impact of dyspnea on health-related quality of life in patients with coronary artery disease: Results from the PREMIER registry.
Autorzy :
Arnold SV
Spertus JA
Jones PG
Xiao L
Cohen DJ
Pokaż więcej
Źródło :
American Heart Journal; Jun2009 Supplement, Vol. 157 Issue 6, p1042-1049.e1, 1p
Czasopismo naukowe
Tytuł :
Correspondence to European Heart Journal-Quality of Care and Clinical Outcomes in response to letter by Dalal H. et al.
Autorzy :
Thomas M; Cardiovascular Research, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.; Department of Biomedical and Health Informatics, University of Missouri-Kansas City, Kansas City, MO, USA.
Jones PG; Cardiovascular Research, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.; Department of Biomedical and Health Informatics, University of Missouri-Kansas City, Kansas City, MO, USA.
Cohen DJ; Department of Biomedical and Health Informatics, University of Missouri-Kansas City, Kansas City, MO, USA.
Arnold SV; Cardiovascular Research, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.; Department of Biomedical and Health Informatics, University of Missouri-Kansas City, Kansas City, MO, USA.
Magnuson EA; Cardiovascular Research, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.
Thourani VH; Department of Cardiovascular Surgery, Marcus Valve Center, Piedmont Heart Institute, 95 Collier Road Northwest, Suite 5015 Atlanta, GA 30309, USA.
Fonarow GC; Department of Internal Medicine, Division of Cardiology, Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.
Sandhu AT; Division of Cardiology, Department of Medicine, Stanford University, Stanford, CA, USA.
Spertus JA; Cardiovascular Research, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.; Department of Biomedical and Health Informatics, University of Missouri-Kansas City, Kansas City, MO, USA.
Pokaż więcej
Źródło :
European heart journal. Quality of care & clinical outcomes [Eur Heart J Qual Care Clin Outcomes] 2021 Jul 21; Vol. 7 (4), pp. e8.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Composite Metric for Benchmarking Site Performance in Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry.
Autorzy :
Desai ND; Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia (N.D.D., J.E.B.).; Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, Leonard Davis Institute of Health Economics, Philadelphia, PA (N.D.D., J.E.B.).
O'Brien SM; Duke Clinical Research Institute, Duke University, Durham, NC (S.M.O., S.V., P.M.).
Cohen DJ; St Francis Hospital, Roslyn, NY (D.J.C.).; Cardiovascular Research Foundation, New York (D.J.C.).
Carroll J; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora (J.C.).
Vemulapalli S; Duke Clinical Research Institute, Duke University, Durham, NC (S.M.O., S.V., P.M.).
Arnold SV; Department of Cardiovascular Medicine, Saint Luke's Mid America Heart Institute, Kansas City, MO (S.V.A.).
Forrest JK; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT (J.K.F.).
Thourani VH; Department of Surgery, Piedmont Hospital, Atlanta, GA (V.H.T.).
Kirtane AJ; Department of Medicine, Columbia University, New York (A.J.K.).
O'Neil B; Division of Cardiology, Henry Ford Hospital, Detroit, MI (B.O.).
Manandhar P; Duke Clinical Research Institute, Duke University, Durham, NC (S.M.O., S.V., P.M.).
Shahian DM; Division of Cardiac Surgery and Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston (D.M.S.).
Badhwar V; Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown (V.B.).
Bavaria JE; Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia (N.D.D., J.E.B.).; Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, Leonard Davis Institute of Health Economics, Philadelphia, PA (N.D.D., J.E.B.).
Pokaż więcej
Źródło :
Circulation [Circulation] 2021 Jul 20; Vol. 144 (3), pp. 186-194. Date of Electronic Publication: 2021 May 05.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
#SoMe for #IC: Optimal use of social media in interventional cardiology.
Autorzy :
Goldsweig AM; Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
Galper BZ; Mid-Atlantic Permanente Medical Group, McLean, Virginia.
Alraies C; Division of Cardiovascular Medicine, Detroit Medical Center, Detroit, Michigan.
Arnold SV; Division of Cardiovascular Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
Daniels M; Manchester Heart Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, and Division of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, and Division of Cell Matrix Biology and Regenerative Medicine, University of Manchester, Manchester, UK.
Capodanno D; Department of General Surgery and Medical-Surgical Subspecialties, University of Catania, Catania, Italy.
Tarantini G; Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua Medical School, Padua, Italy.
Cohen DJ; Division of Cardiovascular Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
Aronow HD; Division of Cardiovascular Medicine, Warren Alpert Medical School, Brown University, and Lifespan Cardiovascular Institute, Providence, Rhode Island.
Pokaż więcej
Źródło :
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2021 Jul 01; Vol. 98 (1), pp. 97-106. Date of Electronic Publication: 2021 Mar 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Five-Year Clinical and Quality of Life Outcomes From the CoreValve US Pivotal Extreme Risk Trial.
Autorzy :
Arnold SV; Saint Luke's Mid America Heart Institute, Kansas City, MO (S.V.A., K.W.).; Department of Medicine, University of Missouri-Kansas City (S.V.A.).
Petrossian G; Saint Francis Hospital, Roslyn, NY (G.P., D.J.C.).
Reardon MJ; Houston Methodist DeBakey Heart & Vascular Center, Houston, TX (M.J.R., N.S.K.).
Kleiman NS; Houston Methodist DeBakey Heart & Vascular Center, Houston, TX (M.J.R., N.S.K.).
Yakubov SJ; Riverside Methodist Hospital, Columbus, OH (S.J.Y.).
Wang K; Saint Luke's Mid America Heart Institute, Kansas City, MO (S.V.A., K.W.).
Hermiller J Jr; St Vincent's Medical Center, Indianapolis, IN (J.H.).
Harrison JK; Department of Medicine, Duke University Medical Center, Durham, NC (J.K.H.).
Deeb GM; Department of Surgery, University of Michigan Medical Center, Ann Arbor, MI (G.M.D.).
Huang J; Medtronic, Minneapolis, MN (J.H.).
Cohen DJ; Saint Francis Hospital, Roslyn, NY (G.P., D.J.C.).; Clinical Trials Center, Cardiovascular Research Foundation, NY (D.J.C.).
Pokaż więcej
Corporate Authors :
US CoreValve Investigators
Źródło :
Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2021 Jun; Vol. 14 (6), pp. e010258. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Relationship Between Residual Mitral Regurgitation and Clinical and Quality-of-Life Outcomes After Transcatheter and Medical Treatments in Heart Failure: The COAPT Trial.
Autorzy :
Kar S; Los Robles Regional Medical Center, Thousand Oaks, CA; Bakersfield Heart Hospital, Bakersfield, CA.
Mack MJ; Baylor Scott & White Heart Hospital Plano, Plano, TX.
Lindenfeld J; Advanced Heart Failure and Cardiac Transplantation Section, Vanderbilt Heart and Vascular Institute, Nashville, TN.
Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH.
Asch FM; MedStar Health Research Institute, Washington, DC; Georgetown University, Washington, DC.
Weissman NJ; MedStar Health Research Institute, Washington, DC; Georgetown University, Washington, DC.
Enriquez-Sarano M; Mayo Clinic, Rochester, MN.
Lim DS; Division of Cardiology, University of Virginia, Charlottesville, VA.
Mishell JM; Kaiser Permanente - San Francisco Hospital, San Francisco, CA.
Whisenant BK; Intermountain Heart Center, Salt Lake City, UT.
Rogers JH; University of California Davis Medical Center, Sacramento, CA.
Arnold SV; Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City School of Medicine, Kansas City, MO.
Cohen DJ; St Francis Hospital, Roslyn, NY; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY.
Grayburn PA; Baylor University Medical Center, Baylor Heart and Vascular Institute, Dallas, TX.
Stone GW; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Pokaż więcej
Źródło :
Circulation [Circulation] 2021 May 27. Date of Electronic Publication: 2021 May 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical Care: A Review.
Autorzy :
Thomas M; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City.
Jones PG; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City.
Arnold SV; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City.
Spertus JA; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City.
Pokaż więcej
Źródło :
JAMA cardiology [JAMA Cardiol] 2021 May 01; Vol. 6 (5), pp. 593-599.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Association between sacubitril/valsartan initiation and real-world health status trajectories over 18 months in heart failure with reduced ejection fraction.
Autorzy :
Thomas M; Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, 4401 Wornall Road, Kansas City, MO, 64111, USA.
Khariton Y; Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, 4401 Wornall Road, Kansas City, MO, 64111, USA.
Fonarow GC; Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.
Arnold SV; Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, 4401 Wornall Road, Kansas City, MO, 64111, USA.
Hill L; Duke Clinical Research Institute, Durham, NC, USA.
Nassif ME; Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, 4401 Wornall Road, Kansas City, MO, 64111, USA.
Chan PS; Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, 4401 Wornall Road, Kansas City, MO, 64111, USA.
Butler J; University of Mississippi, Jackson, MS, USA.
Thomas L; Duke Clinical Research Institute, Durham, NC, USA.
DeVore AD; Duke Clinical Research Institute, Durham, NC, USA.; Division of Cardiology, Department of Medicine, and the Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Hernandez AF; Duke Clinical Research Institute, Durham, NC, USA.; Division of Cardiology, Department of Medicine, and the Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Albert NM; Cleveland Clinic, Cleveland, OH, USA.
Patterson JH; Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
Williams FB; Mended Hearts, Huntsville, AL, USA.
Spertus JA; Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, 4401 Wornall Road, Kansas City, MO, 64111, USA.
Pokaż więcej
Źródło :
ESC heart failure [ESC Heart Fail] 2021 May 01. Date of Electronic Publication: 2021 May 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study.
Autorzy :
Bongaerts B; Institute for Biometrics and Epidemiology, German Diabetes Center Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf, Dusseldorf, Germany .
Arnold SV; Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.; University of Missouri Kansas City, Kansas City, Missouri, USA.
Charbonnel BH; Department of Endocrinology, University of Nantes, Paris, France.
Chen H; AstraZeneca, Gaithersburg, Maryland, USA.
Cooper A; AstraZeneca, Cambridge, UK.
Fenici P; AstraZeneca, Cambridge, UK.
Gomes M; Internal Medicine, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Ji L; Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
Khunti K; Leicester Diabetes Centre, University of Leicester, Leicester, UK.
Kosiborod M; Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.; University of Missouri Kansas City, Kansas City, Missouri, USA.
Medina J; AstraZeneca, Madrid, Spain.
Nicolucci A; Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy.
Shestakova M; Endocrinology Research Centre, Moscow, Russian Federation.
Shimomura I; Osaka University School of Medicine Graduate School of Medicine, Suita, Japan.
Tang F; Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.
Watada H; Juntendo University School of Medicine Graduate School of Medicine, Bunkyo-ku, Japan.
Rathmann W; Institute for Biometrics and Epidemiology, German Diabetes Center Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf, Dusseldorf, Germany.
Pokaż więcej
Źródło :
BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2021 May; Vol. 9 (1).
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Hypoglycemia*
Aged ; Glucose ; Glycated Hemoglobin A/analysis ; Humans ; Hypoglycemic Agents/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies